MedInTech Inc.
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Medintech ranks #36,435 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.
- #36,435
- of 49,997 US assignees by volume
- 42nd percentile
- by Innovation Score (32.6/100)
- 8.3
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R36435 · Foreign Corporation #36,435 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 7 grants
- MID-PACK #36,435/49,997
- PHOTO-FINISH Mayne Pharma
- CPC-NARROW A61B · 4 areas
- INNOV-THIN 32.6/100
- CLAIMS-PAR 8.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2024–2025 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Mayne Pharma LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medintech’s 32.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medintech
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- MedInTech · this assignee 33
MedInTech · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medintech's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medintech?
Each dot is one of Medintech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medintech’s own 8.3 claims/patent is at or below the 13.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Medintech's grants concentrate
MedInTech Inc. is a focused PatentsView assignee: 4 CPC subclasses with 85.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Medintech sits between Mayne Pharma LLC and Mederi RF, LLC.
Medintech's three-year grant acceleration
MedInTech Inc. shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at MedInTech's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mayne Pharma
Mayne Pharma LLC
7 patents
- Mchale Engineering
McHale Engineering
7 patents
- Mcnaughton Incorp…
McNaughton Incorporated
7 patents
- Med-life Discover…
Med-Life Discoveries LP
7 patents
- Medrhythms
MedRhythms, Inc.
7 patents
- Medtrace Pharma A…
MedTrace Pharma A/S
7 patents
- Medcomb Holding A…
Medcomb Holding APS
7 patents
- Mederi RF
Mederi RF, LLC
7 patents
- Medintech ◀
MedInTech Inc.
7 patents
What this shows MedInTech holds 7 patents at rank #36,481, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near MedInTech
By rank, the assignees closest to #36,481 in granted patent volume.
- Mayne Pharma LLC #36,477 · 7 patents
- McHale Engineering #36,478 · 7 patents
- McNaughton Incorporated #36,479 · 7 patents
- Med-Life Discoveries LP #36,480 · 7 patents
- MedRhythms, Inc. #36,482 · 7 patents
- MedTrace Pharma A/S #36,483 · 7 patents
- Medcomb Holding APS #36,484 · 7 patents
- Mederi RF, LLC #36,485 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in MedInTech's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Medintech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 42nd percentile higher than 42% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 2 | 28.6% |
| 2025partial year | 5 | 71.4% |
Which technologies does MedInTech Inc. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
MedInTech Inc.'s patent record in context - here's where to go next.
- MedInTech Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 85.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #36,435 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare MedInTech Inc. against Mayne Pharma LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.